Literature DB >> 14476206

Effects of antiparkinson drugs on a phenothiazine-induced catatonic reaction.

C MORPURGO.   

Abstract

Entities:  

Keywords:  CATATONIA/experimental; PARASYMPATHOLYTICS/pharmacology; TRANQUILIZING AGENTS/pharmacology

Mesh：

Substances：

Year:  1962        PMID： 14476206

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN： 0003-9780


× No keyword cloud information.
  9 in total

1.  Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects.

Authors:  A C Sayers; H R Bürki; W Ruch; H Asper
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

2.  Studies on the central effects of bulbocapnine.

Authors:  A Loizzo; A S De Carolis; V G Longo
Journal:  Psychopharmacologia       Date:  1971

3.  Red Lentil Extract: Neuroprotective Effects on Perphenazine Induced Catatonia in Rats.

Authors:  Gholamreza Houshmand; Shahram Tarahomi; Ardeshir Arzi; Mehdi Goudarzi; Mohammad Bahadoram; Mohammadreza Rashidi-Nooshabadi
Journal:  J Clin Diagn Res       Date:  2016-06-01

4.  The production of an alternative laboratory model of the Parkinson syndrome using a new benzylimidoylurea derivative LON 954.

Authors:  D M Coward; N S Doggett
Journal:  Psychopharmacology (Berl)       Date:  1977-04-29       Impact factor: 4.530

5.  Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism.

Authors:  S Kaakkola; L Ahtee
Journal:  Psychopharmacology (Berl)       Date:  1977-03-23       Impact factor: 4.530

6.  SOME PHARMACOLOGICAL PROPERTIES OF THIOPROPERAZINE AND THEIR MODIFICATION BY ANTI-PARKINSONIAN DRUGS.

Authors:  G B LESLIE; D R MAXWELL
Journal:  Br J Pharmacol Chemother       Date:  1964-04

7.  D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.

Authors:  A Verma; S K Kulkarni
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Neuroprotective effects of Wharton's jelly-derived mesenchymal stem cells on motor deficits due to Parkinson's disease.

Authors:  Maryam Sadat Jalali; Alireza Sarkaki; Yaghoub Farbood; Seyed Saeed Azandeh; Esrafil Mansouri; Mohammad Ghasemi Dehcheshmeh; Ghasem Saki
Journal:  Iran J Basic Med Sci       Date:  2021-09       Impact factor: 2.699

9.  Peganum Harmala L. Extract Reduces Oxidative Stress and Improves Symptoms in 6-Hydroxydopamine-Induced Parkinson's Disease in Rats.

Authors:  Maryam Rezaei; Sima Nasri; Mehrdad Roughani; Zeinab Niknami; Seyed Ali Ziai
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.